Inflammopharmacology

Lipoxygenase inhibition: the neglected frontier for regulating chronic inflammation and pain

M. W. Whitehouse, K. D. Rainsford

Professor William Watson Buchanan, MB ChB, MD, FRCP (Glas., Edin., C.), FRACP, FRCP (Hon; Ireland), FACR (Hon)

Current status of the therapeutic uses and actions of the preferential cyclo-oxygenase-2 NSAID, nimesulide

K. D. Rainsford

Therapeutic use of cephazolin to prevent complications of spine surgery

R. Walters, B. Vernon-Roberts, R. Fraser, R. Moore

Porphyromonas gingivalis lipopolysaccharide-induced cytosolic phospholipase A2 activation interferes with salivary mucin synthesis via platelet activating factor generation

B. L. Slomiany, A. Slomiany

Paracetamol [acetaminophen]-induced gastrotoxicity: revealed by induced hyperacidity in combination with acute or chronic inflammation

K. D. Rainsford, M. W. Whitehouse

Reduced inflammatory potential of peritoneal macrophages recruited in mice pretreated with a glycolipid synthesis inhibitor

H. C. Yohe, T. J. Kitzmiller, W. J. Bement, B. E. Dwyer, J. F. Sinclair

Arthritic disease suppression and cartilage protection with glycosaminoglycan polypeptide complexes (Peptacans) derived from the cartilage extracellular matrix: a novel approach to therapy

P. Ghosh, S. Shimmon, M. W. Whitehouse

Protective effects of nedocromil sodium and sodium cromoglycate on gastroduodenal ulcers: a comparative study in rats

Mohammad Tariq, Meshal Al Moutaery, Ibrahim Elfaki, Mohammad Arshaduddin, Haseeb Ahmad Khan